Found: 186
Select item for more details and to access through your institution.
An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitor-naïve patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mutations.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Adjuvant Pembrolizumab in Patients with Stage IIIA/N2 Non–Small Cell Lung Cancer Completely Resected after Neoadjuvant Concurrent Chemoradiation: A Prospective, Open-Label, Single-Arm, Phase 2 Trial.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 4, p. 1084, doi. 10.4143/crt.2024.084
- By:
- Publication type:
- Article
First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 6, p. 1569, doi. 10.1007/s00432-019-02862-x
- By:
- Publication type:
- Article
Impact of EGFR mutation on the clinical efficacy of PD-1 inhibitors in patients with pulmonary adenocarcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 5, p. 1341, doi. 10.1007/s00432-019-02889-0
- By:
- Publication type:
- Article
Molecular profiles of EGFR, K-ras, c-met, and FGFR in pulmonary pleomorphic carcinoma, a rare lung malignancy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2011, v. 137, n. 8, p. 1203, doi. 10.1007/s00432-011-0986-0
- By:
- Publication type:
- Article
The different efficacy of gefitinib or erlotinib according to epidermal growth factor receptor exon 19 and exon 21 mutations in Korean non-small cell lung cancer patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2011, v. 137, n. 4, p. 687, doi. 10.1007/s00432-010-0928-2
- By:
- Publication type:
- Article
Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLC.
- Published in:
- Clinical Pharmacology in Drug Development, 2018, v. 7, n. 5, p. 532, doi. 10.1002/cpdd.427
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife Radiosurgery.
- Published in:
- Journal of Korean Neurosurgical Society, 2021, v. 64, n. 2, p. 271, doi. 10.3340/jkns.2020.0135
- By:
- Publication type:
- Article
Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non‐small cell lung cancer.
- Published in:
- European Journal of Immunology, 2021, v. 51, n. 4, p. 956, doi. 10.1002/eji.202048966
- By:
- Publication type:
- Article
MDSC subtypes and CD39 expression on CD8<sup>+</sup> T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC.
- Published in:
- European Journal of Immunology, 2020, v. 50, n. 11, p. 1810, doi. 10.1002/eji.202048534
- By:
- Publication type:
- Article
Characteristics and outcomes of RET-rearranged Korean non-small cell lung cancer patients in real-world practice.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 5, p. 594, doi. 10.1093/jjco/hyaa019
- By:
- Publication type:
- Article
Different clinical outcomes between locally advanced hypopharyngeal and oropharyngeal cancer treated with definitive concurrent chemoradiotherapy: implication for subgroup selection for induction chemotherapy.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 1, p. 40, doi. 10.1093/jjco/hyv163
- By:
- Publication type:
- Article
Tuberculosis in hematopoietic stem cell transplant recipients in Korea.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Phase II trial of epidermal growth factor ointment for patients with Erlotinib-related skin effects.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Characteristics and Clinical Outcomes of Non-small Cell Lung Cancer Patients in Korea With MET Exon 14 Skipping.
- Published in:
- In Vivo, 2020, v. 34, n. 3, p. 1399, doi. 10.21873/invivo.11920
- By:
- Publication type:
- Article
Prognostic role of insulin-like growth factor receptor-1 expression in small cell lung cancer.
- Published in:
- APMIS, 2009, v. 117, n. 12, p. 861, doi. 10.1111/j.1600-0463.2009.02545.x
- By:
- Publication type:
- Article
L1 cell adhesion molecule as a predictor for recurrence in pulmonary carcinoids and large-cell neuroendocrine tumors.
- Published in:
- APMIS, 2009, v. 117, n. 2, p. 140, doi. 10.1111/j.1600-0463.2009.02433.x
- By:
- Publication type:
- Article
Preoperative Concurrent Chemoradiotherapy for Stage IIIA Non-Small Cell Lung Cancer.
- Published in:
- Acta Oncologica, 2001, v. 40, n. 5, p. 588, doi. 10.1080/028418601750444123
- By:
- Publication type:
- Article
Pretreatment Clinical Mediastinal Nodal Bulk and Extent do not Influence Survival in N2-Positive Stage IIIA Non-small Cell Lung Cancer Patients Treated with Trimodality Therapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, n. 6, p. 2083, doi. 10.1245/s10434-014-3540-x
- By:
- Publication type:
- Article
Genomic Landscape of Non-Small Cell Lung Cancer (NSCLC) in East Asia Using Circulating Tumor DNA (ctDNA) in Clinical Practice.
- Published in:
- Current Oncology, 2022, v. 29, n. 3, p. 2154, doi. 10.3390/curroncol29030174
- By:
- Publication type:
- Article
Prognostic value of <sup>18</sup>F-FDG PET/CT in patients with squamous cell carcinoma of the tonsil: Comparisons of volume-based metabolic parameters.
- Published in:
- Head & Neck, 2013, v. 35, n. 1, p. 15, doi. 10.1002/hed.22904
- By:
- Publication type:
- Article
Fractionated stereotactic radiation therapy for locally recurrent nasopharynx cancer: Report of three cases.
- Published in:
- Head & Neck, 1999, v. 21, n. 4, p. 338, doi. 10.1002/(SICI)1097-0347(199907)21:4<338::AID-HED8>3.0.CO;2-9
- By:
- Publication type:
- Article
Clinical outcomes of immune checkpoint inhibitors for patients with recurrent or metastatic head and neck cancer: real-world data in Korea.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Characteristics and outcomes of ALK+ non-small cell lung cancer patients in Korea.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2017, v. 13, n. 5, p. e239, doi. 10.1111/ajco.12645
- By:
- Publication type:
- Article
The Effect of N/ P Ratio on the In Vitro and In Vivo Interaction Properties of PEGylated Poly[2-(dimethylamino)ethyl methacrylate]- Based si RNA Complexes.
- Published in:
- Macromolecular Bioscience, 2013, v. 13, n. 8, p. 1059, doi. 10.1002/mabi.201300046
- By:
- Publication type:
- Article
ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non‐small cell lung cancer.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 265, doi. 10.1007/s10637-021-01121-6
- By:
- Publication type:
- Article
Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 360, doi. 10.1007/s10637-019-00795-3
- By:
- Publication type:
- Article
Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 5, p. 625, doi. 10.1007/s10637-016-0368-1
- By:
- Publication type:
- Article
AZD9291 overcomes T790 M-mediated resistance through degradation of EGFR in non-small cell lung cancer cells.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 4, p. 407, doi. 10.1007/s10637-016-0350-y
- By:
- Publication type:
- Article
BYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancer.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
BYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 1, p. 12, doi. 10.1007/s10637-014-0163-9
- By:
- Publication type:
- Article
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 5, p. 841, doi. 10.1007/s10147-021-01869-0
- By:
- Publication type:
- Article
Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non–Small–Cell Lung Cancer (PACIFIC).
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 6, p. 549, doi. 10.1016/j.cllc.2021.05.009
- By:
- Publication type:
- Article
Comparison of SP142 and 22C3 Immunohistochemistry PD-L1 Assays for Clinical Efficacy of Atezolizumab in Non–Small Cell Lung Cancer: Results From the Randomized OAK Trial.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. 21, doi. 10.1016/j.cllc.2021.05.007
- By:
- Publication type:
- Article
Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional Tests.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Transthoracic Rebiopsy for Mutation Analysis in Lung Adenocarcinoma: Outcomes and Risk Factors for the Acquisition of Nondiagnostic Specimens in 199 Patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and Safety of Lorlatinib in Korean Non-Small-Cell Lung Cancer Patients With ALK or ROS1 Rearrangement Whose Disease Failed to Respond to a Previous Tyrosine Kinase Inhibitor.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Review of Regimens Combining Pemetrexed With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in the Treatment of Advanced Nonsquamous Non-Small-Cell Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Survival Outcome Assessed According to Tumor Burden and Progression Patterns in Patients With Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma Undergoing Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 3, p. 228, doi. 10.1016/j.cllc.2014.11.002
- By:
- Publication type:
- Article
Vertical Magnetic Separation of Circulating Tumor Cells for Somatic Genomic-Alteration Analysis in Lung Cancer Patients.
- Published in:
- Scientific Reports, 2016, p. 37392, doi. 10.1038/srep37392
- By:
- Publication type:
- Article
Expanded Access Program Pralsetinib in Advanced Non-Small Cell Lung Cancer with Rearranged during Transfection (RET) Gene Rearrangement.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1144, doi. 10.4143/crt.2023.403
- By:
- Publication type:
- Article
Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1104, doi. 10.4143/crt.2023.502
- By:
- Publication type:
- Article
Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non–Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 1, p. 83, doi. 10.4143/crt.2021.1571
- By:
- Publication type:
- Article
Long-term Survival in Non-Small Cell Lung Cancer Patients with Metachronous Brain-Only Oligorecurrence Who Underwent Definitive Treatment.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 1, p. 150, doi. 10.4143/crt.2021.306
- By:
- Publication type:
- Article
EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 4, p. 1288, doi. 10.4143/crt.2020.278
- By:
- Publication type:
- Article
Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in Korea.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 1, p. 292, doi. 10.4143/crt.2019.186
- By:
- Publication type:
- Article
EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 2, p. 493, doi. 10.4143/crt.2018.125
- By:
- Publication type:
- Article
Clinical Outcomes of EGFR Exon 20 Insertion Mutations in Advanced Non-small Cell Lung Cancer in Korea.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 2, p. 623, doi. 10.4143/crt.2018.151
- By:
- Publication type:
- Article
Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 2, p. 502, doi. 10.4143/crt.2018.117
- By:
- Publication type:
- Article
Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients with Extensive-Disease Small Cell Lung Cancer.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 1, p. 119, doi. 10.4143/crt.2018.019
- By:
- Publication type:
- Article